Key Trends Reshaping the Injectable Drug Delivery Devices Market: Advancements In Auto-Injectors For Enhanced Injectable Drug Delivery Devices Industry Transformation

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Injectable Drug Delivery Devices Market Size Growth Forecast: What to Expect by 2025?
The market size for injectable drug delivery devices has seen substantial growth recently. The market is predicted to grow from a value of $49.59 billion in 2024, to $54.3 billion in 2025, experiencing a compound annual growth rate (CAGR) of 9.5%. Factors contributing to the growth during the historical period include a swift rise in the number of elderly individuals, an increase in the number of healthcare facilities, a hike in healthcare spending, progress in the field of biologics, and growing awareness around self-administration.

How Will the Injectable Drug Delivery Devices Market Size Evolve and Grow by 2029?
The market size of injectable drug delivery devices is predicted to experience substantial growth in the coming years, reaching a value of $73.85 billion in 2029 with a compound annual growth rate (CAGR) of 8.0%. The projected growth in this sector during the forecast period is as a result of factors including the increasing incidence of chronic illnesses, intensifying demand for injectable drugs, abrupt emergence of serious infections, and a multitude of drugs and vaccines under various stages of clinical trials. Key trends in this timeframe comprise a concentration on the production of microneedle-based drug delivery systems, investment in self-injectable devices' research and development, attention on wearables production, prioritising needle-free injection systems' production, broadening product line to include prefilled syringes, looking into enhancement of digital technology in their devices, and innovating in device and auto-injectors manufacturing.

View the full report here:
https://www.thebusinessresearchcompany.com/report/injectable-drug-delivery-devices-global-market-report

What Drivers Are Propelling the Growth of Injectable Drug Delivery Devices Market Forward?
The rising inclination towards self-injection devices propels the growth in the market for injectable drug delivery devices. Self-injection devices are medical tools, intended to be utilized by patients for self-medication in their homes. The categories of self-injection devices encompass needle-free, auto, pen, and wearable injectors. The design of these self-injecting devices is meant to offer highly accurate drug delivery and be simple to operate. Moreover, novel advancements in self-injectable devices have augmented their acceptance over the recent years. The BD Physioject, produced by Becton, dic*kinson, and Company, is a single-use auto-injector proven to be clinically effective, dependable, cost-efficient and tailored for self-administration of medication by chronic disease patients such as those with rheumatoid arthritis, multiple sclerosis, asthma, and osteoporosis. Several other firms such as AbbVie, Inc., 3M, Baxter, Gerresheimer AG, Pfizer Inc. also participate in the self-injection market. The merits of self-injectable injections coupled with heightened awareness about self-administration have boosted the demand for such devices and are set to stimulate the injectable drug delivery devices market in the forecasted period.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2835&type=smp

What Trends Will Shape the Injectable Drug Delivery Devices Market Through 2029 and Beyond?
Companies involved in the creation of injectable drug delivery systems are intensifying their efforts in producing auto-injectors. Auto-injectors are fully automatic, heavily personalized, and reusable injection devices that allow patients to administer hundreds of injections by themselves. The patients have control over the delivery speed of the dosage to reduce pain or discomfort associated with the injection process. These tools can vary the speed and depth of the injection. For instance, Unilife corporation manufactures a reusable auto-injector called LISA, which is equipped with numerous customizable features such as Bluetooth LE connectivity, Wi-Fi or 3G connectivity, and pre-injection drug warming for specific therapies. The market for injectable drug delivery technology is projected to experience substantial growth in the near future due to various technological progresses and the introduction of new products aimed at enhancing the ease and convenience of administering parenteral therapeutics.

What Are the Key Segments in the Injectable Drug Delivery Devices Market?
The injectable drug delivery devices market covered in this report is segmented -

1) By Type: Syringes, Injectors And Pump
2) By Application: Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Other Applications
3) By End-user: Hospitals And Clinics, Home Healthcare Settings, Pharmaceutical And Biotechnological Companies, Research Laboratories, Other End Users

Subsegments:
1) By Syringes: Conventional Syringes, Prefilled Syringes, Safety Syringes
2) By Injectors: Autoinjectors, Pen Injectors, Needle-Free Injectors
3) By Pumps: Insulin Pumps, Ambulatory Infusion Pumps, Implantable Pumps

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2835&type=smp

Who Are the Key Players Shaping the Injectable Drug Delivery Devices Market's Competitive Landscape?
Major companies operating in the injectable drug delivery devices market include Becton, dic*kinson and Company, Baxter International, Gerresheimer AG, Catalent, Inc., SkyePharma PLC, Antares Pharma, Pfizer Inc, GE Healthcare, Owen Mumford, Catalent Pharma Solutions, Philips, West Pharmaceutical Services, Inc., Alkermes, Schott AG, UCB, AstraZeneca, Johnson & Johnson, NEARMEDIC PLUS LLC, Pendant Biosciences, Siemens, H&T Presspart, B Braun, Copernicus, Ypsomed AG, 3M Company, Aptar, Congenica Ltd., Julphar, Nemera, Stryker, Roche, Nektar Therapeutics, Eli Lilly, Merck & Co. Inc., Sandoz, Sorrel Medical, Teleflex Medical, Gilero, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline, MediPrint Ophthalmics, Medtronic, Novartis, Pharmasyntez, Bayer, Mylan N.V, Aptalis Pharma, Inc., Sanofi, Novo Nordisk, Bilim Pharmaceuticals, Battelle Medical Devices, Caplin Steriles Limited, Abbot, Allergan, Boehringer Ingelheim, Hovione Technology, Jiangsu Delfu Medical Device Co, Ltd., Syqe Medical, Terumo Corporation, Kedalion Therapeutics, Amgen Inc.

What Geographic Markets Are Powering Growth in the Injectable Drug Delivery Devices Market?
North America was the largest region in the injectable drug delivery devices market in 2024. Western Europe was the second-largest region in the global injectable drug delivery devices market. The regions covered in the injectable drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2835

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.